Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Novavax COVID Vaccine to Be Adapted to JN.1 Strain: Takeda
June 10, 2024
- Shionogi Gets Option Rights to Cilcare’s Hearing Loss Assets
June 10, 2024
- Maruho Licenses Amenalief Rights in 10 ASEAN States to Singapore Firm
June 7, 2024
- Overseas Sales Ratio of 25 Japan Drug Makers Reaches 67% in FY2023: Tally
June 6, 2024
- TAK-861 Hits Main Goal in PIIb Trial, PIII Set to Begin in 1H FY2024: Takeda
June 6, 2024
- Shionogi to Open Antimicrobial R&D Center in San Diego
June 6, 2024
- Enhertu Scores in Earlier Line for HER2-Low Breast Cancer, Shows Promise in Ultralow Cases
June 6, 2024
- PeptiDream Doses 1st Patient with CA9-Targeted Radiopeptide
June 6, 2024
- Japan Vaccine Market Projected to Top 280 Billion Yen in FY2024: Fuji Keizai
June 6, 2024
- PharmaEssentia’s Besremi Gets Health Coverage for Self-Injection
June 5, 2024
- China Outpaces US in Oncology Trials, Japan’s Share Sags: IQVIA
June 5, 2024
- Twymeeg Tops April GP Rep Promotion Rankings: Intage
June 5, 2024
- Lilly’s Ulcerative Colitis Therapy Omvoh Now Available for Self-Injection
June 4, 2024
- Regeneron Takes Over Japan Marketing Authorization for Libtayo from Sanofi
June 4, 2024
- Organon Launches Fertility Med Follistim after Re-Submission
June 4, 2024
- EU Panel OKs Adzynma for cTTP under Exceptional Circumstances
June 4, 2024
- Janssen Files Amivantamab for Post-Tagrisso NSCLC Setting in Japan
June 3, 2024
- Bayer, Kyoto University Form Strategic Alliance to Fuel Innovation
June 3, 2024
- Tapinarof Cream Hits Main Goal in PIII Eczema Trial in Children: JT/Torii
June 3, 2024
- ASKA Extends Relugolix Combo Deal with Takeda into Endometriosis
June 3, 2024
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…